Revenues for pSivida Corp. totaled $3.5 million for the fiscal year ending June 30, 2014, marking an increase of $1.4 million from the previous year, the company announced in a press release.The increase in revenues was mainly attributed to recognition…
Author: Healio ophthalmology
Aerie, Deerfield reach $125 million debt financing agreement
Aerie Pharmaceuticals announced it has received a $125 million financing commitment from Deerfield Management Company that is expected to be funded before the end of the month, subject to customary closing conditions.With the financing provided by Deer…
Exfoliation syndrome linked to sunlight exposure
Ocular exposure to sunlight may be an important risk factor for exfoliation syndrome, according to findings from a study. Researchers conducted the clinic-based, case-control study in the United States and Israel. All study participants were white and …
Pars plana vitrectomy most cost-effective for VMA, macular hole
Pars plana vitrectomy was the most cost-effective treatment for vitreomacular adhesion and full-thickness macular hole, according to study findings.Researchers culled data from the MIVI-TRUST study and from published clinical trials on Jetrea (ocriplas…
Statins before diabetes diagnosis did not increase microvascular disease risk
Patients treated with statins before being diagnosed with diabetes are not at increased risk for microvascular disease, according to data published in The Lancet Diabetes & Endocrinology.The possibility raised in a study conducted by Danish researchers that statins could actually protect against the small vessel disease requires further investigation, according to the study researchers.
CMS extends Open Payments deadline to Sept. 11
Due to prior outages, CMS announced it is extending the review, dispute and correction process deadline for its Open Payments System by one more day, to Sept. 11 at midnight.CMS closed the Open Payments system on Aug. 2 after errors and intermingled da…
Ophthotech meets $50 million enrollment milestone under Novartis agreement
Ophthotech Corporation announced in a press release that it has reached a $50 million enrollment milestone payment from Novartis Pharma. The payment is part of the ex-U.S. licensing and commercialization agreement between the two companies with a commo…
Cynosure completes acquisition of Ellman International
Cynosure announced it has acquired the assets of Ellman International for approximately $13.2 million in cash.Under the acquisition, Cynosure also assumed certain contractual and current liabilities associated with normal working capital, according to …
Reduced susceptibility to natamycin linked to larger infiltrate, perforation risk
Researchers have found that decreased susceptibility to natamycin is associated with increased 3-month infiltrate or scar size and increased chances of perforation. The researchers enrolled 323 patients in a randomized, double-masked clinical trial to compare clinical outcomes of topical natamycin monotherapy with that of voriconazole monotherapy for the treatment of fungal keratitis. Associations between minimum inhibitory concentration (MIC) and clinical outcomes were assessed. The study’s primary outcome was best corrected visual acuity at 3 months.
Cyclosporine has scant effect on corneal neovascularization after PK
High-dose subconjunctival cyclosporine implants had an insignificant effect on corneal neovascularization after high-risk penetrating keratoplasty, according to a study.“This suggests that local [subconjunctival cyclosporine] has negligible anti-angiogenic effects in the human cornea, at least in the transplant setting,” the study authors said. “This is in contrast to prolonged use of topical steroids, which now has been shown in several randomized trials to promote corneal graft survival.”
Alphaeon to acquire Clarion
Alphaeon will acquire all outstanding shares and assets of Clarion Medical Technologies, according to an Alphaeon press release.The amount of the acquisition was undisclosed. The deal is expected to close on or before Sept. 30, according to the release.
Refractive lenticule extraction yields stable visual, refractive outcomes at 5 years
Femtosecond laser-assisted refractive lenticule extraction offered long-term stability in correcting myopia and myopic astigmatism, according to a study.The prospective clinical trial included 41 eyes of 22 patients who underwent the procedure. A 200 k…
Jetrea approved in South Korea for symptomatic vitreomacular adhesion
Jetrea has been approved in South Korea for the treatment of symptomatic vitreomacular adhesion, according to a ThromboGenics press release.This is the fourth country in Asia, behind Malaysia, Singapore and Taiwan, to approve the intravitreal injection.
Aerie reports Q2 cash, equivalents and investments of $56.6 million
Aerie Pharmaceuticals reported second-quarter cash, cash equivalents and investments of $56.6 million, according to a company press release. The net loss attributable to common stockholders was $11.8 million, or $0.49 per share, compared with $6.5 mill…
Top ophthalmic business news
The competitive landscape for ophthalmic and optometry business revenue has been apparent in recent weeks as industries have announced their Q2 earnings, acquisitions, pending agreements and other breaking news. Here are the Ocular Surgery News editors…
SIGS live surgery at Kalpavriksha 2014
Soosan Jacob, MS, FRCS, DNB, started stab incision glaucoma surgery (SIGS) as a new option for a guarded filtration procedure. It involves the creation of a compromised leaking corneoscleral tunnel with minimal to no conjunctival dissection, according to Jacob.In this video, Jacob performs live SIGS during the Kalpavriksha annual conference in Chennai.
Clearside granted fourth U.S. patent for microneedle drug delivery methods, devices
The U.S. Patent and Trademark Office has granted a fourth patent to Clearside Biomedical for its proprietary microneedle drug delivery methods and devices, according to a Clearside press release.The patent, “Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle,” provides exclusivity for the administration of any drug to a patient’s eye by inserting a hollow microneedle into the eye and infusing the drug into the suprachoroidal space.
Aerie announces phase 3 registration trial of Rhopressa in Canada
Aerie Pharmaceuticals announced it recently initiated a phase 3 registration trial of Rhopressa, a once-daily, triple-action eye drop designed to lower IOP in patients with glaucoma or ocular hypertension, according to a company press release. The stud…
Allergan provides update on written requests for special stockholders’ meeting
Allergan has provided an update concerning the validity of stockholders’ written requests for a special stockholders’ meeting, the company announced in a press release.The requests were delivered by Pershing Square Capital Management, which is attempting to complete a merger between Allergan and Valeant Pharmaceuticals.
Allergan provides update on written requests for special stockholders’ meeting
Allergan has provided an update concerning the validity of stockholders’ written requests for a special stockholders’ meeting, the company announced in a press release.The requests were delivered by Pershing Square Capital Management, which is attempting to complete a merger between Allergan and Valeant Pharmaceuticals.